US FDA Allows Booster Shots for Children Aged 12 to 15

Pfizer Vaccine Booster Shot Interval Shortened to 5 Months

[Image source=AP Yonhap News]

[Asia Economy New York=Correspondent Baek Jong-min] The United States is starting COVID-19 booster shot vaccinations for children aged 12 to 15.

The U.S. Food and Drug Administration (FDA) announced on the 3rd (local time) that it has decided to lower the eligible age for booster shot vaccinations from 16 and older to 12 and older.

Children can receive the Pfizer vaccine just like adolescents aged 16 to 17.

The FDA also shortened the interval between the second Pfizer vaccine dose and the booster shot from the current 6 months to 5 months. For the Moderna vaccine, the booster shot can still be administered 6 months after the second dose as before.

The FDA stated that children aged 5 to 11 with immune system issues can also receive the booster shot, but it has not decided on vaccinations for healthy children. CNBC reported that the FDA may consider vaccinations for children depending on changes in the situation.

The FDA's decision is expected to be finalized this week after approval by the Centers for Disease Control and Prevention (CDC).

Albert Bourla, CEO of Pfizer, said in a statement, "The recent spread of COVID-19 infections is concerning. The FDA's decision is a very important step to overcome the pandemic. Booster shots are essential to maintain a high level of protection and reduce hospitalization rates."

This content was produced with the assistance of AI translation services.